BACKGROUND: Nitrous oxide inactivates vitamin B 12 , inhibits methionine synthase, and consequently increases plasma total homocysteine (tHcy). Prolonged exposure to nitrous oxide can lead to neuropathy, spinal cord degeneration, and even death in children. We tested the hypothesis that nitrous oxide anesthesia causes a significant increase in plasma tHcy in children. METHODS: Twenty-seven children (aged 10 -18 years) undergoing elective major spine surgery were enrolled, and serial plasma samples from 0 to 96 hours after induction were obtained. The anesthetic regimen, including the use of nitrous oxide, was at the discretion of the anesthesiologist. Plasma tHcy was measured using standard enzymatic assays. RESULTS: The median baseline plasma tHcy concentration was 5.1 mol/L (3.9 -8.0 mol/L, interquartile range) and increased in all patients exposed to nitrous oxide (n ϭ 26) by an average of ϩ9.4 mol/L (geometric mean; 95% confidence interval, 7.1-12.5 mol/L) or ϩ228% (mean; 95% confidence interval, 178%-279%). Plasma tHcy peaked between 6 and 8 hours after induction of anesthesia. One patient who did not receive nitrous oxide had no increase in plasma tHcy. Several patients experienced a severalfold increase in plasma tHcy (maximum ϩ567%). The increase in plasma tHcy was strongly correlated with the duration and average concentration of nitrous oxide anesthesia (r ϭ 0.80; P Ͻ 0.001). CONCLUSIONS: Pediatric patients undergoing nitrous oxide anesthesia develop significantly increased plasma tHcy concentrations. The magnitude of this effect seems to be greater compared with adults; however, the clinical relevance is unknown. (Anesth Analg 2011;113: 843-8) 
N itrous oxide (N 2 O) has an unusual toxic side effect, unrelated to its anesthetic action: it inactivates vitamin B 12 (cobalamin). 1, 2 The inactivation of cobalamin and cobalamin-dependent enzymes, such as methionine synthase, is chemically irreversible and can last clinically up to 1 week until new enzyme is synthesized. 3 In patients, the inactivating effects of N 2 O on cobalamin can be observed by an increase in plasma total homocysteine (tHcy) because methionine synthase, the enzyme responsible for the conversion of homocysteine to methionine, requires cobalamin as coenzyme. 4, 5 Clinically, cobalamin inactivation by N 2 O and the subsequent increase in plasma tHcy and methionine deficiency can lead to megaloblastic bone marrow changes, 6 neuropathy, 7 severe spinal cord degeneration, 8 and even death, particularly in patients with preexisting inborn or acquired disorders of folate metabolism. In 2003, the death of a 4-month-old infant with a previously unknown severe deficiency in a core enzyme of the folate cycle was attributed to the use of N 2 O. 9 The safety of N 2 O has been questioned, both in adult 10 and pediatric patients. 11 However, the inactivating effects of N 2 O on cobalamin and subsequent increase in plasma tHcy have never been systematically investigated in children. To our knowledge, this is the first study to test the hypothesis that N 2 O anesthesia causes a significant increase in plasma tHcy in children.
METHODS
This was an ancillary study, performed on residual plasma samples, from a pharmacokinetic study of approved anesthetic drugs in children, which was approved by the Washington University IRB. Written informed consent was obtained from parents and assent from children. The ancillary study also received IRB approval.
Study Design
The parent study included pediatric patients scheduled for elective major spine surgery. Most patients had idiopathic scoliosis. Patients could be included if they met the following inclusion criteria: age 5 to 18 years; undergoing general anesthesia and surgery with anticipated postoperative inpatient stay of Ն3 days; and signed, written informed consent from legal guardians and assent from the patient. Patients were excluded if they had a history of liver or kidney disease, or were pregnant or nursing females. An additional inclusion criterion for the ancillary study was that sufficient residual plasma samples were available.
The patients received standard general anesthesia and monitoring. The protocol did not specify the choice of anesthetic drugs, including the use of N 2 O, which were left at the sole discretion of the anesthesia team.
Measurements
Plasma samples obtained at baseline and 1, 2, 4, 6, 8, 12, 24, 48, 72 , and 96 hours after induction of anesthesia were analyzed. Baseline samples were obtained immediately after an IV line was placed, usually after inhaled induction of anesthesia. Blood samples were immediately put on ice and spun down within 2 hours of collection. Samples were then frozen at Ϫ80°C until assayed.
Plasma tHcy was measured on a Roche Hitachi 917 analyzer using the Diazyme homocysteine enzymatic assay (Diazyme Laboratories, Poway, CA) with reagents from Genzyme (Cambridge, MA). This assay has excellent correlation with high-performance liquid chromatography and immunochemical methods with a linear range of 3 to 50 mol/L and inter %CV (coefficient of variation) values of Ͻ5%. 12 
Statistical Analysis
Peak plasma tHcy concentrations were compared with baseline tHcy and absolute and relative changes were calculated. Cumulative N 2 O exposure was calculated as the product of average N 2 O concentration used (as fraction of 1) and the duration of N 2 O exposure (N 2 O⅐min). As an example, if a patient had a N 2 O anesthesia duration of 300 minutes at 50% concentration (ϭ0.5), the resultant product would be 150 N 2 O⅐min. This calculation was done by hand from paper anesthesia records with measurements every 5-minute interval.
To model the effects of N 2 O anesthesia on plasma tHcy in this longitudinal dataset, we used a linear mixed regression model (random slopes and random intercepts) with log-transformed tHcy as a dependent variable and a firstorder autoregressive covariance structure. 13 Several models were compared and the most parsimonious chosen based on Ϫ2LL (negative log-likelihood) or Akaike Information Criterion. A linear correlation was examined between N 2 O⅐min and peak tHcy using the Pearson correlation coefficient and a simple linear regression was performed; results include the 95% confidence intervals. All reported tests are 2-sided and a P value Ͻ0.05 was considered statistically significant.
RESULTS
In this study, 27 pediatric patients from the parent study cohort (n ϭ 30) were included (Table 1 ). Most patients underwent idiopathic scoliosis repair.
At baseline, the median plasma tHcy concentration was 5.1 mol/L (0.9 -9.8 mol/L; min-max) and several patients (5 of 18 females, 28%; 0 of 9 males, 0%) met the diagnostic criteria for mild hyperhomocysteinemia (normal range for plasma tHcy at 12-19 years of age: female, 3.3-7.2 mol/L; male, 4.3-9.9 mol/L) ( Table 1) .
All except 1 pediatric patient received N 2 O intraoperatively. Four children were only briefly (Ͻ30 minutes) exposed to N 2 O during induction of or emergence from general anesthesia. The remaining 23 patients received N 2 O (average concentration 55%) for the full duration of the spine surgery, which in some patients lasted up to 10 hours. All children who were exposed to N 2 O (n ϭ 26) had a subsequent increase in their plasma tHcy concentration by an average of ϩ9.4 mol/L (geometric mean; 95% confidence interval [CI], 7.1-12.5 mol/L) or ϩ228% (mean; 95% CI, 178%-279%) ( Fig. 1 , Table 2 ). The increase in plasma tHcy was highly significant and peaked between 6 and 8 hours ( Fig. 2) , usually immediately after the cessation of general anesthesia. Most children experienced a severalfold increase of their plasma tHcy concentration (maximum: ϩ567%) and the maximum observed peak concentration was 38.6 mol/L. The highest tHcy levels were observed in children with high baseline plasma tHcy levels. No difference was observed between female and male patients. A linear mixed model was used to model the effects of N 2 O exposure on plasma tHcy within each individual patient and among all patients. The results of the mixed model show a statistically highly significant difference among all patients (P Ͻ 0.001), the time points (P Ͻ 0.001), and also a significant effect of the cumulative N 2 O dose (N 2 O⅐min, P ϭ 0.02) and time point. Twenty-four hours after anesthesia start time, plasma tHcy concentrations largely reverted to their baseline levels.
The magnitude of the increase in plasma tHcy caused by N 2 O was strongly correlated with the product of duration of N 2 O anesthesia and average N 2 O concentration used (N 2 O⅐min) (Pearson r ϭ 0.80; 95% CI, 0.61-0.91; P Ͻ 0.0001) ( Fig. 3 ). More than 64% of the observed variation in plasma tHcy increase could be explained by the N 2 O⅐min variable, making it a strong and significant predictor.
DISCUSSION
This study showed that pediatric patients develop a significant increase in plasma tHcy when receiving N 2 O during prolonged general anesthesia. Some children in our study developed a 400% to 600% increase from their baseline plasma tHcy levels, signifying a magnitude of an inhibitory effect of N 2 O on folate and methionine metabolism that is larger than frequently observed in adult patients. Even though our patients had very long N 2 O anesthesia durations, comparable studies in adults reported increases in plasma tHcy of only between 50% and 80%. Badner et al. 4 reported a 74% increase; Myles et al. 14 Ͼ8 hours of anesthesia; and our own previous study showed an increase of 80% for Ͼ4 hours of N 2 O anesthesia. 15 Only Ermens et al. 3 showed comparable results, although only reported as correlation. Our findings suggest that children experience an at least similar, if not greater, inhibition of methionine synthase and folate metabolism by N 2 O, but the lack of comparable pediatric studies makes it difficult to generalize the results from a single study. Baseline plasma tHcy levels varied widely within our study population, and several children had mild hyperhomocysteinemia (normal range for plasma tHcy at 12-19 years of age: female, 3.3-7.2 mol/L; male, 4.3-9.9 mol/L). Baseline plasma tHcy levels vary within the population and are influenced by environmental (nutrition, folic acid and vitamin B 12 intake) and genetic factors, most importantly the MTHFR C677T polymorphism, considered the most important genetic predictor. 16 A surprising finding of this study was that nearly all plasma tHcy levels reverted into the normal range after 24 hours, irrespective of the magnitude of the increase caused by N 2 O. Until now, it was commonly believed and reported from adult patients that N 2 O-induced hyperhomocysteinemia extends well beyond the immediate postoperative period and can last up to 1 week after exposure. 3 Whether children have a better ability to recover from N 2 Oinduced inhibition of methionine synthase compared with adults or this observation was specific for our study population is unclear. A possible explanation may be that our patients experienced large shifts in their fluid balance including intravascular volume resuscitation and blood transfusions, which may have decreased plasma homocysteine concentrations.
only 50% even after
What is the clinical relevance of these findings? Two related but separate issues need to be addressed. First is the question of adverse drug reactions caused by N 2 O's inhibition of methionine synthase. Over the last 60 years, a multitude of case reports and series have been published showing the following adverse clinical outcomes unequivocally and directly attributed to N 2 O's inactivation of vitamin B 12 and subsequent inhibition of methionine synthase: fatal 9 and nonfatal 17 neurologic degeneration, myelopathy, 8,18 -21 peripheral neuropathy, 7,22-25 bone marrow depression and megaloblastic bone marrow changes, 6,26 -31 and an increased risk for infection. 32, 33 Mostly these toxic side effects were observed only after prolonged or repeated exposure to N 2 O (Ͼ24 hours) or among N 2 O drug abusers. Although these effects are apparently fairly uncommon, N 2 O clearly can cause hematologic and neurologic side effects that may be irreversible and/or fatal. The true incidence of the adverse neurologic and hematologic effects of N 2 O when used in a clinically appropriate manner and dose has never been systematically investigated, neither in adults nor children.
The second question is, What are the clinical consequences of an acute increase in plasma homocysteine concentrations? This question is much more difficult to answer. As the substrate for methionine synthase, homocysteine accumulates because of the inhibition by N 2 O. It is therefore possible that an acute increase in plasma tHcy in itself causes no additional adverse effects; alternatively, a direct toxic effect of increased plasma tHcy may also be possible. Whereas a chronic plasma homocysteine increase at the level observed in our study (up to 40 mol/L) is unequivocally associated with a substantially increased risk of atherosclerosis, coronary artery disease, 34 and premature death in adults, 35 as well as venous thromboembolism in children, 36 the effects of an acute increase in plasma tHcy are largely unknown. The direct effects of an acute increase in blood homocysteine levels on the cardiovascular system have mostly been shown experimentally [37] [38] [39] and have not been unequivocally correlated with any clinical outcomes (separate from N 2 O's inhibition of methionine synthase).
This study has several strengths and limitations. It must be emphasized that this study was exploratory in nature, taking advantage of a unique opportunity to collect serial blood samples in a pediatric population, and therefore was not designed to investigate any clinical outcomes.
The present observational study did not have a formal control group that did not receive N 2 O. Two independent lines of evidence strongly suggest that, in our study, the exposure to N 2 O was causally linked to the subsequent increase in plasma tHcy. First, it is generally accepted that in nonexperimental, observational studies, the presence of a dose-response relationship infers, but naturally does not prove, causality. In our study, a very strong relationship between the cumulative N 2 O dose and subsequent increase in homocysteine was found (r ϭ 0.80). Second, it has been repeatedly shown in Ͼ6 human studies (Ͼ1000 patients) that in the absence of N 2 O, patients will not develop an increase in postoperative plasma tHcy. 3,4,14,40 -42 Based on these preexisting data, it is a reasonable prediction that we would have observed a similar result (no increase in plasma tHcy without N 2 O) if our study had had a formal control group.
The study was limited in its generalizability because it enrolled mostly teenagers undergoing major spine surgery and no patient younger than 10 years of age. No study has investigated the interaction among N 2 O, folate metabolism, and homocysteine in younger children (0 -10 years) thus far, so our findings should not be extrapolated to younger children. Because most of our patients had scoliosis, it is possible that the findings of this study were influenced by scoliosis-associated conditions or spine surgery (prone position, large fluid shifts). Our study did not determine any influence of gene variants, most notably the MTHFR C677T polymorphism, which is considered the most important genetic predictor for baseline blood tHcy concentrations and which also has a significant effect on the increase in plasma tHcy after N 2 O anesthesia. 15 
CONCLUSIONS
This study showed that children undergoing N 2 O anesthesia develop significantly increased plasma tHcy concentrations. The clinical relevance of this observation is unknown and would require well-designed randomized controlled trials.
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